Temporal comparisons of immune status and target organ histology in mice fed carcinogenic 5-nitrofurans and their nornitro analogs.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D002273:Carcinogens; D004032:Diet; D005200:FANFT / Q000031:analogs & derivatives / Q000633:toxicity; D005260:Female; D005663:Furans / Q000633:toxicity; D007111:Immunity, Cellular / Q000187:drug effects; D007942:Leukemia, Experimental / Q000139:chemically induced / Q000276:immunology* / Q000473:pathology; D008221:Lymphoid Tissue / Q000187:drug effects / Q000473:pathology; D051379:Mice; D008807:Mice, Inbred BALB C; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000276:immunology / Q000473:pathology; D009581:Nitrofurans / Q000633:toxicity*; D013844:Thiazoles / Q000633:toxicity*; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced / Q000276:immunology* / Q000473:pathology
D002273:Carcinogens; D005663:Furans; D009581:Nitrofurans; D013844:Thiazoles; C005327:furothiazole; C029651:N-(4-(2-furyl)-2-thiazolyl)acetamide; C029650:N-(4-(2-furyl)-2-thiazolyl)formamide; D005200:FANFT